Skip to Main Content

Author Details

Yeran Li
Iowa State University
2011
12
7
PMIDPaper TitleJournal TitlePublished Year
31767855JASPer controls interphase histone H3S10 phosphorylation by chromosomal kinase JIL-1 in Drosophila.Nat Commun2019
29447188Comparing deep learning and concept extraction based methods for patient phenotyping from clinical narratives.PLoS One2018
30485354Evidence for a role of spindle matrix formation in cell cycle progression by antibody perturbation.PLoS One2018
29500024Behind the scenes: A medical natural language processing project.Int J Med Inform2018
28807902H2Av facilitates H3S10 phosphorylation but is not required for heat shock-induced chromatin decondensation or transcriptional elongation.Development2017
24429699Histone H3S10 phosphorylation by the JIL-1 kinase in pericentric heterochromatin and on the fourth chromosome creates a composite H3S10phK9me2 epigenetic mark.Chromosoma2014
25072297The spindle matrix protein, Chromator, is a novel tubulin binding protein that can interact with both microtubules and free tubulin.PLoS One2014
24598257Genome-wide analysis of regulation of gene expression and H3K9me2 distribution by JIL-1 kinase mediated histone H3S10 phosphorylation in Drosophila.Nucleic Acids Res2014
23723094Domain requirements of the JIL-1 tandem kinase for histone H3 serine 10 phosphorylation and chromatin remodeling in vivo.J Biol Chem2013
23638096Evidence against a role for the JIL-1 kinase in H3S28 phosphorylation and 14-3-3 recruitment to active genes in Drosophila.PLoS One2013
22634714H3S10 phosphorylation by the JIL-1 kinase regulates H3K9 dimethylation and gene expression at the white locus in Drosophila.Fly (Austin)2012
22247192The epigenetic H3S10 phosphorylation mark is required for counteracting heterochromatic spreading and gene silencing in Drosophila melanogaster.J Cell Sci2011
  • 1 - 12 of 12

Recommended Authors

Damien Goutte-Gattat
University of Cambridge
Career Start Year 2010
Number of shared co-authors 0
Raghuvar Dronamraju
University of North Carolina at Chapel Hill School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Jesse J Lipp
Research Institute of Molecular Pathology (IMP)
Career Start Year 2005
Number of shared co-authors 0
Andreas Rechtsteiner
University of California
Career Start Year 2004
Number of shared co-authors 0
Cheng-Fu Kao
Institute of Cellular and Organismic Biology
Career Start Year 2003
Number of shared co-authors 0
Tiaojiang Xiao
National Institute of Diabetes and Digestive and Kidney Diseases
Career Start Year 2002
Number of shared co-authors 0
Vincent Vanoosthuyse
Ecole Normale Superieure de Lyon, CNRS
Career Start Year 2001
Number of shared co-authors 0
Nicolas Lacoste
Institut NeuroMyoGene, Universite Lyon1-CNRS UMR1-INSERM U1315
Career Start Year 2001
Number of shared co-authors 0
Tibor van Welsem
Netherlands Cancer Institute
Career Start Year 2000
Number of shared co-authors 0
Michael-Christopher Keogh
EpiCypher Inc.
Career Start Year 1997
Number of shared co-authors 0
Seong Hoon Ahn
College of Science and Convergence Technology, Hanyang University
Career Start Year 1997
Number of shared co-authors 0
Zhiguo Zhang
Institute for Cancer Genetics, Columbia University Irving Medical Center
Career Start Year 1997
Number of shared co-authors 0
Brian D Strahl
University of North Carolina
Career Start Year 1996
Number of shared co-authors 0
Asifa Akhtar
Max Planck Institute of Immunobiology and Epigenetics
Career Start Year 1996
Number of shared co-authors 0
Jason D Lieb
The University of Chicago
Career Start Year 1996
Number of shared co-authors 0
Martin Zofall
National Cancer Institute, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 0
Zu-Wen Sun
EpiCypher Inc.
Career Start Year 1995
Number of shared co-authors 0
Giovanni Bosco
Geisel School of Medicine at Dartmouth
Career Start Year 1994
Number of shared co-authors 0
Scott D Briggs
Purdue University
Career Start Year 1993
Number of shared co-authors 0
Jennifer L Gerton
Stowers Institute for Medical Research
Career Start Year 1992
Number of shared co-authors 0
Bas van Steensel
Oncode Institute, Netherlands Cancer Institute
Career Start Year 1991
Number of shared co-authors 0
Ali Shilatifard
Northwestern University Feinberg School of Medicine
Career Start Year 1991
Number of shared co-authors 1
Jacques C??t??
Centre Hospitalier Universitaire (CHU) de Quebec-Universite Laval Research Center
Career Start Year 1987
Number of shared co-authors 0
Shelley L Berger
Penn Epigenetics Institute, Perelman School of Medicine
Career Start Year 1985
Number of shared co-authors 0
Fred van Leeuwen
Netherlands Cancer Institute, University of Amsterdam
Career Start Year 1983
Number of shared co-authors 0
Susan M Gasser
L'Institut Suisse de Recherche Experimentale sur le Cancer (ISREC) Foundation
Career Start Year 1982
Number of shared co-authors 0
Gary H Karpen
University of California Berkeley
Career Start Year 1981
Number of shared co-authors 0
Danny Reinberg
HHMI/NYU Langone School of Medicine
Career Start Year 1980
Number of shared co-authors 0
Lorraine Pillus
University of California San Diego
Career Start Year 1980
Number of shared co-authors 0
C David Allis
The Rockefeller University
Career Start Year 1974
Number of shared co-authors 1

Collaborators

Franck Dernoncourt
Massachusetts Institute of Technology
Co-authored papers 2
Edward T Moseley
Dana-Farber Cancer Institute, Tufts University
Co-authored papers 2
David W Grant
Washington University School of Medicine
Co-authored papers 2
Patrick D Tyler
Beth Israel Deaconess Medical Center
Co-authored papers 2
Leo Anthony Celi
Harvard T.H. Chan School of Public Health, MIT
Co-authored papers 2
Eric T Carlson
Johns Hopkins University School of Medicine
Co-authored papers 2
Sebastian Gehrmann
Heinrich-Heine-University Duesseldorf
Co-authored papers 2
Joy T Wu
Stanford University
Co-authored papers 2
Jonathan Welt
University of Michigan ann arbor
Co-authored papers 2
John Foote
Tufts University School of Medicine
Co-authored papers 1
Tom W Muir
Princeton University
Co-authored papers 1
Release 1.2